Login / Signup

Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.

Clémentine RoucherIsabel BrosiusMoustapha MbowBabacar Thiendella FayeAnnelies De HondtBart SmekensDiana ArangoChristophe BurmAchilleas TsoumanisLinda ParedisYven van HerrewegeIdzi PottersBadara CisseSouleymane MboupKatja PolmanEmmanuel Bottieau
Published in: BMJ open (2021)
NCT03893097; pre-results.
Keyphrases
  • open label
  • study protocol
  • randomized controlled trial
  • clinical trial
  • young adults
  • phase ii
  • squamous cell carcinoma
  • phase iii
  • radiation therapy
  • rectal cancer